Cytokinetics (CYTK) Current Assets (2010 - 2026)
Cytokinetics (CYTK) reported Current Assets of $1.21 billion for Q2 2026, up 36.3% from $886.54 million a year earlier and up 44.0% from the prior quarter.
Powered by 
Analysis
Cytokinetics (CYTK) Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Cytokinetics posted Current Assets of $916.98 million, down 17.2% from FY2024.
- Current Assets has a five-year compound annual growth rate of 14.1% (FY2020 to FY2025).
- By year, Current Assets came in at $1.11 billion in FY2024 (+76.4%), $628.05 million in FY2023 (-21.0%), $795.19 million in FY2022 (+48.4%) and $535.67 million in FY2021 (+13.0%).
- The Q2 2026 figure ranks as the highest quarterly Current Assets in data going back to Q4 2010.
- Year over year, Current Assets gained in four of the last eight quarters, with growth averaging 24.2%.
- The high point for year-over-year Current Assets in five years was Q2 2024 (growth of 82.0%); the low point was Q3 2023 (a decline of 36.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $839.47 million (Q1 2026), $916.98 million (Q4 2025) and $977.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 59.77 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.67 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 36.68 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 27.35 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 27.97 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.96 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 13.95 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 41.36 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 12.54 Bn |
| 10 | Cytokinetics | 9.20 Bn | 5.37 Bn | 25.89 Mn | 1.21 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.21 Bn |
| Mar 31, 2026 | 839.47 Mn |
| Dec 31, 2025 | 916.98 Mn |
| Sep 30, 2025 | 977.35 Mn |
| Jun 30, 2025 | 886.54 Mn |
| Mar 31, 2025 | 956.05 Mn |
| Dec 31, 2024 | 1.11 Bn |
| Sep 30, 2024 | 1.02 Bn |
| Jun 30, 2024 | 1.07 Bn |
| Mar 31, 2024 | 638.70 Mn |
| Dec 31, 2023 | 628.05 Mn |
| Sep 30, 2023 | 561.42 Mn |
| Jun 30, 2023 | 586.58 Mn |
| Mar 31, 2023 | 680.63 Mn |
| Dec 31, 2022 | 795.19 Mn |
| Sep 30, 2022 | 884.28 Mn |
| Jun 30, 2022 | 602.25 Mn |
| Mar 31, 2022 | 623.53 Mn |
| Dec 31, 2021 | 535.67 Mn |
| Sep 30, 2021 | 494.94 Mn |
API Access
Cytokinetics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CYTK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CYTK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CYTK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();